Tami Michaud

FDA Approves Lebrikizumab for Atopic Dermatitis

FDA Approves Lebrikizumab for Atopic Dermatitis

September 14, 2024

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for the treatment of...

Oncologica to advance urine-based prostate cancer screening test

September 19, 2024

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

September 18, 2024

FDA Approves Benralizumab for EGPA Vasculitis Indication

FDA Approves Benralizumab for EGPA Vasculitis Indication

September 18, 2024

Study finds early puberty linked to higher risk for HS

Study finds early puberty linked to higher risk for HS

September 18, 2024

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

September 18, 2024